Literature DB >> 25320315

Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice.

David J Morales1, Kristen Monte1, Lulu Sun2, Jessica J Struckhoff1, Eugene Agapov1, Michael J Holtzman3, Thaddeus S Stappenbeck2, Deborah J Lenschow4.   

Abstract

UNLABELLED: ISG15 is a diubiquitin-like modifier and one of the most rapidly induced genes upon type I interferon stimulation. Hundreds of host proteins and a number of viral proteins have been shown to be ISGylated, and understanding how these modifications affect the interferon response and virus replication has been of considerable interest. ISG15(-/-) mice exhibit increased susceptibility to viral infection, and in the case of influenza B virus and vaccinia virus, ISG15 conjugation has been shown to restrict virus replication in vivo. A number of studies have also found that ISG15 is capable of antagonizing replication of some viruses in tissue culture. However, recent findings have demonstrated that ISG15 can protect mice from Chikungunya virus infection without affecting the virus burden. In order to better understand the function of ISG15 in vivo, we characterized the pathogenesis of influenza A virus and Sendai virus in ISG15(-/-) mice. We found that ISG15 protects mice from virus induced lethality by a conjugation-dependent mechanism in both of these models. However, surprisingly, we found that ISG15 had minimal effect on virus replication and did not have an obvious role in the modulation of the acute immune response to infection. Instead, we observed an increase in the number of diseased small airways in mice lacking ISG15. This ability of ISG15 to protect mice in a conjugation-dependent, but nonantiviral, manner from respiratory virus infection represents a previously undescribed role for ISG15 and demonstrates the importance of further characterization of ISG15 in vivo. IMPORTANCE: It has previously been demonstrated that ISG15(-/-) mice are more susceptible to a number of viral infections. Since ISG15 is one of the most strongly induced genes after type I interferon stimulation, analysis of ISG15 function has largely focused on its role as an antiviral molecule during acute infection. Although a number of studies have shown that ISG15 does have a small effect on virus replication in tissue culture, few studies have confirmed this mechanism of protection in vivo. In these studies we have found that while ISG15(-/-) mice are more susceptible to influenza A virus and Sendai virus infections, ISGylation does not appear to mediate this protection through the direct inhibition of virus replication or the modulation of the acute immune response. Thus, in addition to showing a novel mode of ISG15 mediated protection from virus infection, this study demonstrates the importance of studying the role of ISG15 in vivo.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25320315      PMCID: PMC4301115          DOI: 10.1128/JVI.02110-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  64 in total

1.  Properties of the ISG15 E1 enzyme UbE1L.

Authors:  Robert M Krug; Chen Zhao; Sylvie Beaudenon
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

2.  Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.

Authors:  Nadia V Giannakopoulos; Jiann-Kae Luo; Vladimir Papov; Weiguo Zou; Deborah J Lenschow; Barbara S Jacobs; Ernest C Borden; Jun Li; Herbert W Virgin; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2005-10-21       Impact factor: 3.575

3.  Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.

Authors:  Atsushi Okumura; Gengshi Lu; Ian Pitha-Rowe; Paula M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-24       Impact factor: 11.205

4.  Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo.

Authors:  Deborah J Lenschow; Nadia V Giannakopoulos; Lacey J Gunn; Christine Johnston; Andy K O'Guin; Robert E Schmidt; Beth Levine; Herbert W Virgin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.

Authors:  Chen Zhao; Carilee Denison; Jon M Huibregtse; Steven Gygi; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-11       Impact factor: 11.205

6.  Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Mary J Pantin-Jackwood; Stacey Schultz-Cherry; Alicia Solórzano; Nico Van Rooijen; Jacqueline M Katz; Christopher F Basler
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells.

Authors:  Anahita Dastur; Sylvie Beaudenon; Melissa Kelley; Robert M Krug; Jon M Huibregtse
Journal:  J Biol Chem       Date:  2005-12-28       Impact factor: 5.157

8.  Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.

Authors:  Keun Il Kim; Ming Yan; Oxana Malakhova; Jiann-Kae Luo; Mei-Feng Shen; Weiguo Zou; Juan Carlos de la Torre; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

9.  ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus.

Authors:  Anna Osiak; Olaf Utermöhlen; Sandra Niendorf; Ivan Horak; Klaus-Peter Knobeloch
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 10.  Immunopathology in influenza virus infection: uncoupling the friend from foe.

Authors:  Daniela Damjanovic; Cherrie-Lee Small; Mangalakumari Jeyanathan; Mangalakumari Jeyananthan; Sarah McCormick; Zhou Xing
Journal:  Clin Immunol       Date:  2012-05-15       Impact factor: 3.969

View more
  18 in total

1.  The impact of ISGylation during Mycobacterium tuberculosis infection in mice.

Authors:  Jacqueline M Kimmey; Jessica A Campbell; Leslie A Weiss; Kristen J Monte; Deborah J Lenschow; Christina L Stallings
Journal:  Microbes Infect       Date:  2017-01-10       Impact factor: 2.700

2.  Zika virus infects cells lining the blood-retinal barrier and causes chorioretinal atrophy in mouse eyes.

Authors:  Pawan Kumar Singh; John-Michael Guest; Mamta Kanwar; Joseph Boss; Nan Gao; Mark S Juzych; Gary W Abrams; Fu-Shin Yu; Ashok Kumar
Journal:  JCI Insight       Date:  2017-02-23

3.  Type I Interferon-Mediated Induction of Antiviral Genes and Proteins Fails to Protect Cells from the Cytopathic Effects of Sendai Virus Infection.

Authors:  Jacquelyn R Bedsaul; Luna A Zaritsky; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2016-08-10       Impact factor: 2.607

Review 4.  Host genetics of severe influenza: from mouse Mx1 to human IRF7.

Authors:  Michael J Ciancanelli; Laurent Abel; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2016-01-04       Impact factor: 7.486

5.  ISG15 Is Upregulated in Respiratory Syncytial Virus Infection and Reduces Virus Growth through Protein ISGylation.

Authors:  Rubén González-Sanz; Manuel Mata; Jesús Bermejo-Martín; Amparo Álvarez; Julio Cortijo; José A Melero; Isidoro Martínez
Journal:  J Virol       Date:  2016-01-13       Impact factor: 5.103

6.  Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins.

Authors:  Chen Zhao; Haripriya Sridharan; Ran Chen; Darren P Baker; Shanshan Wang; Robert M Krug
Journal:  Nat Commun       Date:  2016-09-02       Impact factor: 14.919

7.  ISG15 in Host Defense Against Candida albicans Infection in a Mouse Model of Fungal Keratitis.

Authors:  Chen Dong; Nan Gao; Bing X Ross; Fu-Shin X Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-06-01       Impact factor: 4.799

8.  Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppression.

Authors:  Linda J Visser; Chiara Aloise; Kirby N Swatek; Gisselle N Medina; Karin M Olek; Huib H Rabouw; Raoul J de Groot; Martijn A Langereis; Teresa de Los Santos; David Komander; Tim Skern; Frank J M van Kuppeveld
Journal:  PLoS Pathog       Date:  2020-07-15       Impact factor: 6.823

Review 9.  No Love Lost Between Viruses and Interferons.

Authors:  Volker Fensterl; Saurabh Chattopadhyay; Ganes C Sen
Journal:  Annu Rev Virol       Date:  2015-09-25       Impact factor: 14.263

10.  Aedes aegypti microRNA miR-2b regulates ubiquitin-related modifier to control chikungunya virus replication.

Authors:  Sunil Kumar Dubey; Jatin Shrinet; Jaspreet Jain; Shakir Ali; Sujatha Sunil
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.